Arrowstreet Capital
RMTI icon

Arrowstreet Capital’s Rockwell Medical RMTI Stock Holding History

Arrowstreet Capital’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,596
Closed -$63.2K – 2062
2025
Q1 		$63.2K Sell
5,596
-5,018
-47% -$91.1K ﹤0.01% 1776
2024
Q4 		$217K Sell
10,614
-3,846
-27% -$112K ﹤0.01% 1659
2024
Q3 		$574K Buy
+14,460
New +$389K ﹤0.01% 1496

Other funds holding RMTI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Arrowstreet Capital's RMTI Position: Q2 2025 in Review

Arrowstreet Capital sold out of Rockwell Medical (RMTI) in Q2 2025, closing a stake of 5,596 shares — an estimated $63.2K sold.

Arrowstreet Capital first reported a position in RMTI in Q3 2024 and held it in 3 quarters. The position peaked at $574K in Q3 2024. 41 funds tracked by Wall St. Rank hold RMTI as of Q2 2025.

  • Arrowstreet Capital reported no remaining Rockwell Medical position as of Q2 2025 after selling out during the quarter.
  • Arrowstreet Capital sold 5,596 Rockwell Medical shares in Q2 2025, an estimated $63.2K.
  • Arrowstreet Capital first reported a position in Rockwell Medical in Q3 2024 and held it in 3 quarters.
  • Arrowstreet Capital's Rockwell Medical position peaked at $574K in Q3 2024.
  • 41 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2025.

Based on Arrowstreet Capital's 13F filing for Q2 2025, filed 13 Aug 2025.